These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N, Delecluse P, Andre C. Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829 [Abstract] [Full Text] [Related]
9. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy. Silvestri M, Spallarossa D, Battistini E, Sabatini F, Pecora S, Parmiani S, Rossi GA. J Investig Allergol Clin Immunol; 2002 May; 12(1):52-9. PubMed ID: 12109533 [Abstract] [Full Text] [Related]
11. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus. Piazza I, Bizzaro N. Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664 [Abstract] [Full Text] [Related]
13. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. Wang DH, Chen L, Cheng L, Li KN, Yuan H, Lu JH, Li H. Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386 [Abstract] [Full Text] [Related]
18. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial. Varney VA, Tabbah K, Mavroleon G, Frew AJ. Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781 [Abstract] [Full Text] [Related]
19. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study. Mungan D, Misirligil Z, Gürbüz L. Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581 [Abstract] [Full Text] [Related]